improperly denied access to drugs for heart disease, seizures and asthma, according to a scathing letter sent to WellPoint on Monday from the Centers for Medicare and Medicaid Services. Among other violations, CMS said WellPoint improperly charged its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-WellPoint shares slump on Medicare violations
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account